Luvixasertib (CFI-402257)
Product Specifications
CAS Number
1610759-22-2
Synonyms
Luvixasertib
Target
Serine/threonin kinase
Applications
Cell Cycle
Molecular Formula
C28H30N6O3
Additionnal Information
Luvixasertib (CFI-402257) is an inhibitor of threonine tyrosine kinase (TTK) with IC50 of 1.7 nM and Ki of 0.1 nM, respectively. It is a potential therapeutic for treating hepatocellular carcinoma that works directly by inhibiting cell-cycle checkpoints in cancer cells and indirectly by mobilizing immune cells from the tumor microenvironment.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP221276 200 Reactions
LOC286533 Human qPCR Primer Pair (XM_208445)
Sign In for Pricing
View Details